Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

52 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Survivin inhibition with YM155 ameliorates experimental pulmonary arterial hypertension.
Blanco I, Marquina M, Tura-Ceide O, Ferrer E, Ramírez AM, Lopez-Meseguer M, Callejo M, Perez-Vizcaino F, Peinado VI, Barberà JA. Blanco I, et al. Among authors: lopez meseguer m. Front Pharmacol. 2023 Apr 24;14:1145994. doi: 10.3389/fphar.2023.1145994. eCollection 2023. Front Pharmacol. 2023. PMID: 37188265 Free PMC article.
Lung and heart-lung transplantation in pulmonary arterial hypertension.
López-Meseguer M, Quezada CA, Ramon MA, Lázaro M, Dos L, Lara A, López R, Blanco I, Escribano P, Roman A; REHAP Investigators. López-Meseguer M, et al. PLoS One. 2017 Nov 21;12(11):e0187811. doi: 10.1371/journal.pone.0187811. eCollection 2017. PLoS One. 2017. PMID: 29161284 Free PMC article.
Chronic thromboembolic pulmonary hypertension in Spain: a decade of change.
Martínez-Santos P, Velázquez-Martín MT, Barberá JA, Fernández Pérez C, López-Meseguer M, López-Reyes R, Martínez-Meñaca A, Lara-Padrón A, Domingo-Morera JA, Blanco I, Escribano-Subías P; REHAP investigators. Martínez-Santos P, et al. Rev Esp Cardiol (Engl Ed). 2021 May;74(5):384-392. doi: 10.1016/j.rec.2020.06.006. Epub 2020 Jul 9. Rev Esp Cardiol (Engl Ed). 2021. PMID: 32654945 English, Spanish.
Survival in pulmonary hypertension in Spain: insights from the Spanish registry.
Escribano-Subias P, Blanco I, López-Meseguer M, Lopez-Guarch CJ, Roman A, Morales P, Castillo-Palma MJ, Segovia J, Gómez-Sanchez MA, Barberà JA; REHAP investigators. Escribano-Subias P, et al. Eur Respir J. 2012 Sep;40(3):596-603. doi: 10.1183/09031936.00101211. Epub 2012 Feb 23. Eur Respir J. 2012. PMID: 22362843 Free article.
The Effect of Borderline Pulmonary Hypertension on Survival in Chronic Lung Disease.
Piccari L, Wort SJ, Meloni F, Rizzo M, Price LC, Martino L, Salvaterra E, Scelsi L, López Meseguer M, Blanco I, Callari A, Pérez González V, Tuzzolino F, McCabe C, Rodríguez Chiaradía DA, Vitulo P; REHAR Registry Investigators. Piccari L, et al. Among authors: lopez meseguer m. Respiration. 2022;101(8):717-727. doi: 10.1159/000524263. Epub 2022 Apr 22. Respiration. 2022. PMID: 35462365 Free PMC article.
Real-life experience of inhaled iloprost for patients with pulmonary arterial hypertension: Insights from the Spanish REHAP registry.
Del Pozo R, Blanco I, Hernández-González I, López-Meseguer M, López-Reyes R, Lázaro-Salvador M, Elías-Hernández T, Álvarez-Vega P, Pérez-Peñate GM, Martínez-Meñaca A, Bedate P, Escribano-Subias P; REHAP investigators. Del Pozo R, et al. Int J Cardiol. 2019 Jan 15;275:158-164. doi: 10.1016/j.ijcard.2018.10.012. Epub 2018 Oct 5. Int J Cardiol. 2019. PMID: 30316648
52 results